268 related articles for article (PubMed ID: 28780255)
1. Paget's disease of bone.
Cundy T
Metabolism; 2018 Mar; 80():5-14. PubMed ID: 28780255
[TBL] [Abstract][Full Text] [Related]
2. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).
Rendina D; Falchetti A; Diacinti D; Bertoldo F; Merlotti D; Giannini S; Cianferotti L; Girasole G; Di Monaco M; Gonnelli S; Malavolta N; Minisola S; Vescini F; Rossini M; Frediani B; Chiodini I; Asciutti F; Gennari L
J Endocrinol Invest; 2024 Jun; 47(6):1335-1360. PubMed ID: 38488978
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of Paget's disease].
Kurth AA
Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256
[TBL] [Abstract][Full Text] [Related]
5. Biology and Treatment of Paget's Disease of Bone.
Vallet M; Ralston SH
J Cell Biochem; 2016 Feb; 117(2):289-99. PubMed ID: 26212817
[TBL] [Abstract][Full Text] [Related]
6. Paget's disease of bone: clinical review and update.
Bolland MJ; Cundy T
J Clin Pathol; 2013 Nov; 66(11):924-7. PubMed ID: 24043712
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of Paget's disease of bone.
Reid IR
Expert Opin Pharmacother; 2012 Apr; 13(5):637-46. PubMed ID: 22339140
[TBL] [Abstract][Full Text] [Related]
8. Paget's disease of bone: an update.
Naot D
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):352-8. PubMed ID: 21986510
[TBL] [Abstract][Full Text] [Related]
9. [Paget's disease: case report].
Wegierska M; Ignaczak P; Zalewska J; Jeka S
Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid for Paget's disease of bone.
Maricic M
Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
[TBL] [Abstract][Full Text] [Related]
11. Paget's disease of bone.
Gruener G; Camacho P
Handb Clin Neurol; 2014; 119():529-40. PubMed ID: 24365317
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and management of Paget's disease of bone.
Ralston SH; Langston AL; Reid IR
Lancet; 2008 Jul; 372(9633):155-163. PubMed ID: 18620951
[TBL] [Abstract][Full Text] [Related]
13. The use of zoledronic acid for Paget's disease of bone.
Maricic M
Curr Osteoporos Rep; 2006 Mar; 4(1):40-4. PubMed ID: 16527007
[TBL] [Abstract][Full Text] [Related]
14. Paget's disease of bone.
Siris ES
J Bone Miner Res; 1998 Jul; 13(7):1061-5. PubMed ID: 9661069
[TBL] [Abstract][Full Text] [Related]
15. Persistent effect of zoledronic acid in Paget's disease.
Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
[TBL] [Abstract][Full Text] [Related]
16. Paget's disease of bone.
Tan A; Ralston SH
QJM; 2014 Nov; 107(11):865-9. PubMed ID: 24757095
[TBL] [Abstract][Full Text] [Related]
17. [Paget's disease of bone: Diagnostic and therapeutic updates].
Alaya R; Alaya Z; Nang M; Bouajina E
Rev Med Interne; 2018 Mar; 39(3):185-191. PubMed ID: 28690091
[TBL] [Abstract][Full Text] [Related]
18. Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone.
Cremers SC; Eekhoff ME; Den Hartigh J; Hamdy NA; Vermeij P; Papapoulos SE
J Bone Miner Res; 2003 May; 18(5):868-75. PubMed ID: 12733726
[TBL] [Abstract][Full Text] [Related]
19. Management of Paget's Disease of the Calcaneum.
Humphrey J; Pervez A; Walker R; Abbasian A; Singh S
J Foot Ankle Surg; 2017; 56(2):401-403. PubMed ID: 28089128
[TBL] [Abstract][Full Text] [Related]
20. Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation.
Mangham DC; Davie MW; Grimer RJ
Bone; 2009 Mar; 44(3):431-6. PubMed ID: 19064007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
